PLRX- Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc. (PLRX) has 4 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. PLRX is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 505.6K | $530.9K | - | |
| CFO | 297.2K | $312.1K | - | |
| Other | 44.8K | $47.1K | - | |
| COO | 37.8K | $39.7K | - |
Activity
Buys and sells only
Transactions
10 filings · page 5
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2023 | Coulie Bernard80 | President And CEO | Sale+OE | 30,000 | $19.20 | $575,892.00 | -13.8% | +35.0% | -0.6% | |
| Dec 22, 2022 | Ouimette Mike81 | General Counsel &Corp. Sec'y | Sell | 2,928 | $19.38 | $56,730.88 | -33.0% | +34.2% | -11.2% | |
| Dec 20, 2022 | Cummings Keith Lamont74 | Chief Financial Officer | Sell | 9,643 | $19.10 | $184,204.44 | -10.7% | +45.1% | -14.4% | |
| Dec 20, 2022 | Coulie Bernard80 | President And CEO | Sell | 34,212 | $19.10 | $653,531.31 | -26.7% | +45.1% | -14.4% | |
| Dec 20, 2022 | Lefebvre Eric82 | Chief Medical Officer | Sell | 10,887 | $19.10 | $207,967.83 | -7.0% | +45.1% | -14.4% | |
| Dec 20, 2022 | Ouimette Mike81 | General Counsel &Corp. Sec'y | Sell | 4,719 | $19.10 | $90,144.23 | -34.7% | +45.1% | -14.4% | |
| Dec 20, 2022 | Hull Hans79 | Chief Business Officer | Sell | 8,748 | $19.10 | $167,107.80 | -6.0% | +45.1% | -14.4% | |
| Oct 25, 2022 | Lefebvre Eric82 | Chief Medical Officer | Sell | 5,000 | $25.05 | $125,241.00 | -3.6% | +19.1% | -46.4% | |
| Sep 12, 2022 | Coulie Bernard80 | President And CEO | Sale+OE | 12,502 | $22.54 | $281,851.34 | -17.4% | -21.4% | -30.3% | |
| Jul 12, 2022 | Coulie Bernard80 | President And CEO | Sale+OE | 27,498 | $22.50 | $618,705.00 | -18.8% | +10.2% | -6.6% |